SAPHO Syndrome Complicated by Ankylosing Spondylitis Successfully Treated With Tofacitinib: A Case Report
Synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome, a type of chronic inflammatory disease, is rare and difficult to treat. Osteoarthropathy with skin involvement is the primary clinical manifestation of SAPHO syndrome. The unknown pathogenesis of SAPHO syndrome is speculated t...
Main Authors: | Fangfang Yuan, Jing Luo, Qiong Yang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-05-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2022.911922/full |
Similar Items
-
Successful Treatment of SAPHO Syndrome Complicated with Ankylosing Spondylitis by Secukinumab: A Case Report
by: Wei Tu, et al.
Published: (2023-03-01) -
Secukinumab-induced paradoxical skin lesions,but successful treatment with tofacitinib in SAPHO syndrome: a case report
by: Li Luan, et al.
Published: (2023-03-01) -
Comparative efficacy of infliximab and adalimumab in patients with ankylosing spondylitis
by: Tatyana Valentinovna Mezenova, et al.
Published: (2012-04-01) -
Improvement of overlapping hidradenitis suppurativa and ankylosing spondylitis after the introduction of adalimumab
by: Dubravka Bosnić, et al.
Published: (2016-12-01) -
Dramatic response of synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome to tofacitinib monotherapy: a case report
by: Stéphanie Dierckx, et al.
Published: (2024-02-01)